Liver cancer drug safety checked in 110 patients
NCT ID NCT03963206
First seen Dec 16, 2025 · Last updated May 22, 2026 · Updated 23 times
Summary
This study looked at how safe the drug cabozantinib is for people with advanced liver cancer (hepatocellular carcinoma) who have already tried another treatment called sorafenib. A total of 110 adults took part. The main goal was to track survival and any side effects that required changing the dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHM - Timone
Marseille, France
-
APHP - Hôpital St Antoine
Paris, France
-
CHRU Rennes site pontchaillou
Rennes, France
-
CHRU de Lille-Hôpital Claude Huriez
Lille, France
-
CHU Amiens Picardie - Hôpital Sud
Amiens, France
-
CHU Dupuytren
Limoges, France
-
CHU Jean Minjoz
Besançon, France
-
CHU Toulouse PURPAN
Toulouse, France
-
CHU de St Etienne
Saint-Priest-en-Jarez, France
-
Centre Hospitalier Universitaire de Montpellier
Montpellier, France
-
Centre Hospitalier de Boulogne sur mer
Boulogne-sur-Mer, France
-
Centre hospitalier universitaire Côte de nacre
Caen, France
-
Hospices Civils de Lyon - Hôpital de la Croix Rousse
Lyon, 69004, France
-
Hôpital Avicenne
Bobigny, France
-
Hôpital Beaujon
Clichy, France
-
Hôpital Brabois adulte - CHU de Nancy
Vandœuvre-lès-Nancy, France
-
Hôpital Robert Debré - CHU de Reims
Reims, France
-
Hôpital haut- lévêque
Pessac, France
Conditions
Explore the condition pages connected to this study.